MKI67 and neoplasm: Age at diagnosis, germline predisposing gene mutations, BMI, breast MRI, histological subtype, grading, Ki-67, HER2 expression, clinical T or N stage, type of breast or axillary surgery, type of NACT, TILs in the residual tumor, time from NACT end and surgery, and time from surgery to radiation therapy and adjuvant therapy were not independent predictors of relapse in our cohort.